Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Autonomous Covid-19, Post-Acute Sequelae of SARS-CoV-2 Infection (PASC) and Influenza Treatment System With Machine Learning in Outpatient Settings

NCT06052527 is registered in ClinicalTrials.gov with Lizora LLC as lead sponsor.

NCT NCT06052527
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06052527 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Autonomous Covid-19, Post-Acute Sequelae of SARS-CoV-2 Infection (PASC) and Influenza Treatment System With Machine Learning in Outpatient Settings
Lead sponsor
Lizora LLC
Phase
Observational
Overall status
Completed
Start date
June 16, 2023
Completion date
October 1, 2023
Enrollment
27 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19, influenza, post-covid-19 syndrome